These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18320644)

  • 21. Impaired activation of IFN-gamma+CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy.
    Lindberg E; Andersson B; Hörnquist EH; Magnusson Y
    Cell Immunol; 2010; 263(2):224-9. PubMed ID: 20435301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrocardiogram in chamber hypertrophy and dilatation].
    Alvarez A; Sáenz L; Oliveras C; Sánchez F
    Aten Primaria; 1990 May; 7(5):381-5. PubMed ID: 2151790
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiomyopathy: progress in diagnosis and treatments topics: I. New classification based on etiology of cardiomyopathy; 1. Classification of cardiomyopathy--its past and present status].
    Tsutsui H
    Nihon Naika Gakkai Zasshi; 2014 Feb; 103(2):277-84. PubMed ID: 24724367
    [No Abstract]   [Full Text] [Related]  

  • 24. [The development of signs of dilated cardiomyopathy in patients with nonobstructive hypertrophic cardiomyopathy].
    Shaposhnik II; Shaposhnik OD
    Ter Arkh; 1992; 64(11):125-6. PubMed ID: 1293833
    [No Abstract]   [Full Text] [Related]  

  • 25. [Primary cardiomyopathies. I. Skin tests using cardiac antigen].
    Pietrzak M
    Pol Arch Med Wewn; 1986 Feb; 75(2):102-8. PubMed ID: 3748827
    [No Abstract]   [Full Text] [Related]  

  • 26. [The viral and immunological characteristics of cardiomyopathies and myocarditis].
    Moiseev VS; Ogurtsov PP; Traianova TG; Savinov AP; Lavrova IK; Stepina VN; Shelepin AA; Rukosuev VS; Tereshchenko SE; Korovina EA
    Ter Arkh; 1990; 62(8):77-82. PubMed ID: 2274878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hypertrophic cardiomyopathy with dilated cardiomyopathy-like features].
    Kamogawa Y; Biro S; Tanaka H
    Ryoikibetsu Shokogun Shirizu; 1996; (14):45-8. PubMed ID: 9047793
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differential diagnosis of cardiomyopathies].
    Kawamura K
    Nihon Naika Gakkai Zasshi; 1993 Feb; 82(2):199-203. PubMed ID: 8492024
    [No Abstract]   [Full Text] [Related]  

  • 29. Non-specific autoantibodies in cardiomyopathies and myocardial infarction.
    Syrigou EI; Konstandoulakis MM; Syrigos KN; Kroubouzou H; Kokotou E; Toutouzas P
    J Clin Lab Immunol; 1995; 46(4):155-62. PubMed ID: 8733028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of coronary flow reserve].
    Kuhn H
    Internist (Berl); 1998 Feb; 39(2):217. PubMed ID: 9556738
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristic distribution of circulating autoantibodies against G-protein coupled cardiovascular receptors in patients with idiopathic dilated and hypertrophic cardiomyopathy.
    Matsui S; Fu M
    Int J Cardiol; 1996 May; 54(2):143-7. PubMed ID: 8803678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Stetho-acoustic cardiomyopathy--characteristics in cardiomyopathies studied by echocardiography].
    Ruser HR; Thiel H; Pahl L
    Z Gesamte Inn Med; 1989 Aug; 44(16):497-9. PubMed ID: 2815897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The MELAS syndrome and dilated-hypertrophic cardiomyopathy: a case report].
    Cristofari M; Bertocchi P; Viganò M
    G Ital Cardiol; 1995 Jan; 25(1):69-76. PubMed ID: 7642013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiomyopathies: nosological entities, classification and the pathomorphological aspect of diagnosis].
    Rozenberg VD
    Klin Med (Mosk); 1990 Jun; 68(6):24-30. PubMed ID: 2214634
    [No Abstract]   [Full Text] [Related]  

  • 36. [A correlative analysis of T-lymphocyte subgroup and plasma selenium in patients with dilated cardiomyopathy].
    Liu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Feb; 20(1):10-1. PubMed ID: 1396085
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of dilated cardiomyopathy and hypertrophic cardiomyopathy].
    Kibira S; Miura M
    Nihon Rinsho; 2000 Jan; 58(1):141-6. PubMed ID: 10885302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progression from hypertrophic obstructive cardiomyopathy to dilated cardiomyopathy. Apropos of 4 cases].
    Bourmayan C; Desnos M; Baragan J; Benoit P; Fernandez F; Hagege A; Gay J; Guerot C
    Arch Mal Coeur Vaiss; 1990 Apr; 83(4):537-42. PubMed ID: 2111675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on the association of HLA with idiopathic cardiomyopathy].
    Cai BL; Lou FG; Yan LX
    Zhonghua Nei Ke Za Zhi; 1985 Jan; 24(1):13-6, 61. PubMed ID: 3856508
    [No Abstract]   [Full Text] [Related]  

  • 40. Inflammation in dilated cardiomyopathy.
    Pankuweit S; Ruppert V; Maisch B
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.